July 20, 2017 7:42 PM ET

Healthcare Providers and Services

Company Overview of Ambry Genetics Corp.

Company Overview

Ambry Genetics Corp. provides clinical diagnostics testing services for genetic diseases. It offers gene sequence analysis for cystic fibrosis; and customizable sequencing, genotyping, and microarray services. The company also provides clinical resources that support ongoing clinician education and sharing of data to promote scientific discoveries that help in improving patient management and care. It serves physicians, genetic counselors, and patients. Ambry Genetics Corp. was founded in 1999 and is based in Aliso Viejo, California.

15 Argonaut

Aliso Viejo, CA 92656

United States

Founded in 1999

Phone:

949-900-5500

Fax:

949-900-5501

Key Executives for Ambry Genetics Corp.

Chief Executive Officer, Interim Chief Operating Officer and Interim Chief Scientific Officer
Founder, Chairman of the Board of Directors and President
Chief Commercial Officer
Director of Clinical Affairs
Compensation as of Fiscal Year 2017.

Ambry Genetics Corp. Key Developments

Ambry Genetics Corp., Konica Minolta Healthcare Americas, Inc. - M&A Call

To discuss acquisition of Ambry Genetics Corp.

Konica Minolta To Reportedly Acquire Ambry Genetics

Konica Minolta, Inc. (TSE:4902) plans to acquire Ambry Genetics of the U.S., which uses genetic data to screen for cancer, the Nikkei daily reported. The acquisition will likely cost around $890 million and be Konica Minolta's most expensive, reflecting its ambition to branch out into healthcare as its printer business slows, the business daily reported without citing sources. Konica Minolta will partner semi-government fund Innovation Network Corp of Japan (INCJ) to buy all shares of Ambry, a private firm that uses genetic data to screen for cancer, the Nikkei said. Konica Minolta told Reuters nothing has been decided at this stage. INCJ did not respond to Reuters' requests for comment.

Ambry Genetics Launches Comprehensive Multi-Gene Test for Hereditary Prostate Cancer

Ambry Genetics announced that it has launched ProstateNext, a new 14-gene panel for hereditary prostate cancer. Ambry will feature it at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference taking place September 28-October 1 in Seattle, WA. This also coincides with Prostate Cancer Awareness Month and follows a recent New England Journal of Medicine (NEJM) article demonstrating a higher frequency of germline mutations in men with metastatic prostate cancer. Prostate cancer is the second most common cancer among men in the U.S., representing 10.7% of all new cancer cases in the country. The median age at diagnosis for these men is 66 years. Due to available screening and treatment, prostate cancer in general has excellent survival rates, but death rates are higher in certain men, including those with advanced stage cancer (such as metastatic cancer). Several factors place a man at increased risk for prostate cancer, and these can include family history and germline mutations. Hereditary prostate cancer, the type caused by germline mutations traveling through a family, is believed to account for 5-10% of all prostate cancer (although this estimate is being refined with ongoing research). A germline mutation found in a man with prostate cancer can open the door to individualized prostate cancer treatment and/or screening for it and related cancers.

Similar Private Companies By Industry

Company Name Region
@ Home Medical, Inc. United States
@home approach, llc United States
@Home Care United States
1011 E. Pecan Grove Road, LLC United States
1104 Welsh Road Operations LLC United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
July 6, 2017
--
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ambry Genetics Corp., please visit www.ambrygen.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.